Clinical

Dataset Information

0

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin


ABSTRACT: Colorectal cancer (CRC) is one of the most leading causes of cancer death in China. Although multiple treatment modalities including surgery, radiotherapy and chemotherapy have been developed, the prognosis of advanced CRC still remains poor. While around 30% of resectable advanced CRC could be cured. This study is designed to compare perioperative FOLFIRI versus adjuvant FOLFIRI in resectable advanced CRC who exposed to oxaliplatin in open-label, phase III mode.

DISEASE(S): Local Neoplasm Recurrence,Neoplasm Recurrence, Local,Effects Of Chemotherapy,Colorectal Neoplasms,Metastasis,Neoplasms

PROVIDER: 2162700 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2014-09-10 | GSE54483 | GEO
2014-09-10 | E-GEOD-54483 | biostudies-arrayexpress
2016-08-16 | GSE81472 | GEO
2024-10-17 | GSE237837 | GEO
2016-05-18 | GSE80473 | GEO
2016-05-18 | E-GEOD-80473 | biostudies-arrayexpress
2022-05-13 | E-MTAB-11145 | biostudies-arrayexpress
| PRJNA996913 | ENA
2022-09-16 | GSE207974 | GEO
| PRJEB52817 | ENA